Gaush Meditech Ltd Stock

Equities

2407

KYG3902N1051

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
19.02 HKD -0.94% Intraday chart for Gaush Meditech Ltd +11.88% -49.68%

Financials

Sales 2023 1.41B 194M 1.52B Sales 2024 * 1.61B 222M 1.74B Capitalization 2.61B 360M 2.81B
Net income 2023 174M 24.01M 188M Net income 2024 * 242M 33.4M 261M EV / Sales 2023 3.62 x
Net cash position 2023 * 280M 38.69M 303M Net cash position 2024 * 508M 70.15M 549M EV / Sales 2024 * 1.3 x
P/E ratio 2023
29.4 x
P/E ratio 2024 *
10.7 x
Employees 869
Yield 2023 *
-
Yield 2024 *
-
Free-Float 25.63%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.94%
1 week+11.88%
Current month-2.46%
1 month-0.42%
3 months-43.73%
6 months-51.23%
Current year-49.68%
More quotes
1 week
16.66
Extreme 16.66
20.80
1 month
15.20
Extreme 15.2
20.80
Current year
15.20
Extreme 15.2
42.05
1 year
15.20
Extreme 15.2
49.50
3 years
15.20
Extreme 15.2
56.10
5 years
15.20
Extreme 15.2
56.10
10 years
15.20
Extreme 15.2
56.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 42 18-11-30
Founder 60 17-10-31
Director of Finance/CFO 50 17-12-31
Members of the board TitleAgeSince
Director/Board Member 63 17-12-28
Director/Board Member 47 22-11-10
Founder 60 17-10-31
More insiders
Date Price Change Volume
24-04-26 19.02 -0.94% 39,500
24-04-25 19.2 +6.90% 178,600
24-04-24 17.96 -1.54% 122,800
24-04-23 18.24 +3.64% 26,900
24-04-22 17.6 +3.53% 13,500

Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am EDT

More quotes
Gaush Meditech Ltd is a China-based company mainly engaged in ophthalmology medical business. The Company operates in four segments. Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables. Distribution segment sells brand ophthalmic medical devices and consumables. Technical Services segment provides warranty service, maintenance service and consumables related to after-sales service. Others segment is mainly engaged in equipment leasing business and intellectual property agency services. The Company's products are widely used in the examination, treatment and correction of ophthalmic subspecialty diseases such as fundus disease, cataract, glaucoma, refraction, optometry, ocular surface, and children's ophthalmology.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
17.61 CNY
Average target price
41.34 CNY
Spread / Average Target
+134.78%
Consensus

Annual profits - Rate of surprise